bromocriptine has been researched along with mifepristone in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 12 (75.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Sánchez, A; Sánchez-Criado, JE; Tébar, M | 1 |
| de Jong, FH; Sánchez-Criado, JE; Uilenbroek, JT | 1 |
| Luderer, U; Schwartz, NB | 1 |
| Slappendel, EJ; Uilenbroek, JT; van der Schoot, P | 1 |
| Carrizo, DG; Deis, RP; Jahn, GA | 1 |
| Crapo, L; Miller, JW | 1 |
| Dluhy, RG; Solomon, CG | 1 |
| Ruiz, A; Sánchez-Criado, JE; Tébar, M | 1 |
| Deis, RP; Soaje, M | 1 |
| Gaytán, F; Sánchez, A; Sánchez-Criado, JE; Tébar, M | 1 |
| Aguilar, R; Gaytán, F; Ruiz, A; Sánchez-Criado, JE; Tébar, AM | 1 |
| Mattheij, JA; Ruiz, A; Sánchez-Criado, JE; Tébar, M | 1 |
| Bellido, C; Gaytán, F; Morales, C; Sánchez-Criado, JE | 1 |
2 review(s) available for bromocriptine and mifepristone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The medical treatment of Cushing's syndrome.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Aminoglutethimide; Animals; Bromocriptine; Cushing Syndrome; Cyproheptadine; Dogs; Horses; Humans; Ketoconazole; Metyrapone; Mifepristone; Mitotane; Octreotide; Palliative Care; Pituitary Gland; Radiography; Valproic Acid | 1993 |
14 other study(ies) available for bromocriptine and mifepristone
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Unilateral ovariectomy, flutamide treatment and HCG reverse the anovulatory action of antiprogesterone RU486 in rat.
Topics: Animals; Bromocriptine; Chorionic Gonadotropin; Estradiol; Estrus; Female; Flutamide; Gonadotropins, Pituitary; Mifepristone; Ovariectomy; Ovulation; Progesterone; Rats; Rats, Wistar; Testosterone | 1992 |
Antiprogesterone RU486 increases serum immunoreactive inhibin levels and LH:FSH and testosterone:oestradiol ratios in cyclic rats.
Topics: Animals; Bromocriptine; Estradiol; Estrus; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Inhibins; Luteinizing Hormone; Mifepristone; Ovarian Follicle; Ovary; Pituitary Hormones; Radioimmunoassay; Rats; Stimulation, Chemical; Testosterone | 1992 |
Sex differences in acute luteinizing hormone responses to gonadectomy remain after progesterone antagonist and dopamine agonist treatment.
Topics: Animals; Bromocriptine; Castration; Dopamine Agents; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Male; Mifepristone; Periodicity; Progesterone; Prolactin; Rats; Rats, Inbred Strains; Sex Characteristics | 1991 |
Effect of the progesterone antagonist mifepristone on the hypothalamo-hypophysial-ovarian axis in rats.
Topics: 20-alpha-Dihydroprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Body Weight; Bromocriptine; Delayed-Action Preparations; Female; Gonanes; Hypothalamo-Hypophyseal System; Mifepristone; Organ Size; Ovary; Pituitary Gland; Progesterone; Prolactin; Rats; Uterus | 1990 |
Suckling-induced prolactin release potentiates mifepristone-induced lactogenesis in pregnant rats.
Topics: Animals; Bromocriptine; Caseins; Female; Lactation; Lactose; Mammary Glands, Animal; Mifepristone; Pregnancy; Progesterone; Prolactin; Rats; Receptors, Progesterone | 1989 |
Paraneoplastic endocrine syndromes.
Topics: Acromegaly; Adrenocorticotropic Hormone; Aminoglutethimide; Bromocriptine; Calcitonin; Cushing Syndrome; Diazoxide; Diphosphonates; Estrogens; Fluid Therapy; Hemangiopericytoma; Humans; Hypercalcemia; Hyperthyroidism; Hypoglycemia; Inappropriate ADH Syndrome; Ketoconazole; Mifepristone; Mineralocorticoids; Mitotane; Octreotide; Osteomalacia; Pamidronate; Paraneoplastic Endocrine Syndromes; Phosphorus; Plicamycin; Propylthiouracil; Saline Solution, Hypertonic; Somatostatin; Thyroid Neoplasms | 1994 |
Effect of antiprogestagen RU486 on both natural and prolactin-induced morphological luteolysis in rat..
Topics: Animals; Bromocriptine; Corpus Luteum; Female; Hypophysectomy; Hypothalamo-Hypophyseal System; Kidney; Luteinizing Hormone; Luteolytic Agents; Mifepristone; Organ Size; Pituitary Gland; Progesterone; Prolactin; Rats; Rats, Wistar; Transplantation, Heterotopic | 1994 |
A modulatory role of endogenous opioids on prolactin secretion at the end of pregnancy in the rat.
Topics: Animals; Bromocriptine; Endorphins; Female; Gestational Age; Mifepristone; Naloxone; Oxymorphone; Pregnancy; Pregnancy, Animal; Proestrus; Progesterone; Prolactin; Rats; Rats, Wistar | 1994 |
Evidence that androgens are involved in atresia and anovulation induced by antiprogesterone RU486 in rats.
Topics: Androgens; Animals; Bromocriptine; Chorionic Gonadotropin; Estradiol; Estrus; Female; Flutamide; Follicle Stimulating Hormone; Follicular Atresia; Luteinizing Hormone; Mifepristone; Ovariectomy; Ovulation; Progesterone; Prolactin; Rats; Rats, Wistar; Testosterone | 1993 |
RU486-treated rats show endocrine and morphological responses to therapies analogous to responses of women with polycystic ovary syndrome treated with similar therapies.
Topics: Androgen Antagonists; Animals; Bromocriptine; Disease Models, Animal; Dopamine Agonists; Estrogen Antagonists; Female; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Mifepristone; Ovary; Ovulation; Polycystic Ovary Syndrome; Progesterone; Rats; Rats, Wistar; Tamoxifen | 1996 |
Follicular and luteal progesterone synergize to maintain 5-day cyclicity in rats.
Topics: Animals; Bromocriptine; Corpus Luteum; Estrus; Female; Injections, Subcutaneous; Luteinizing Hormone; Mifepristone; Ovarian Follicle; Progesterone; Rats; Rats, Wistar; Time Factors | 1996 |
Both prolactin and progesterone in proestrus are necessary for the induction of apoptosis in the regressing corpus luteum of the rat.
Topics: Animals; Apoptosis; Bromocriptine; Corpus Luteum; Dopamine Agonists; Female; Gonanes; Hormone Antagonists; Luteolysis; Macrophages; Mifepristone; Proestrus; Progesterone; Prolactin; Rats; Rats, Wistar | 1998 |